ALL vs PDSB · P/E 4.9, rev $18.60B vs $50.7M cap
The Allstate Corporation (ALL) versus PDS Biotechnology Corp (PDSB) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
PDS Biotechnology Corp (PDSB) is a biotechnology company listed on NASDAQ.
Latest reported ALL revenue for 2026-06-30 was $18.60B. Net income was $3.27B. Revenue was up 9.8% from 2026-03-31 to 2026-06-30. ALL currently screens at market cap $56.89B and trailing P/E 4.9.
PDSB does not have a complete income-statement cache yet.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. PDSB currently screens at market cap $50.7M.
Not investment advice. Open the ALL and PDSB stock pages for the full models.
Not investment advice.